Itron, Inc. (NASDAQ:ITRI – Get Free Report) has earned an average recommendation of “Hold” from the thirteen brokerages that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $131.2222.
ITRI has been the subject of several analyst reports. Stephens restated an “overweight” rating and set a $130.00 price target on shares of Itron in a report on Wednesday, May 20th. Roth Capital reissued a “buy” rating and set a $136.00 price objective on shares of Itron in a research report on Wednesday, April 29th. JPMorgan Chase & Co. cut their price objective on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. TD Cowen reduced their price objective on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a report on Friday, May 8th.
View Our Latest Stock Report on ITRI
Itron Stock Performance
Itron (NASDAQ:ITRI – Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. Itron had a return on equity of 19.54% and a net margin of 12.31%.The business had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same quarter in the previous year, the business earned $1.52 earnings per share. The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, equities research analysts predict that Itron will post 6.01 earnings per share for the current fiscal year.
Insider Activity at Itron
In related news, SVP John F. Marcolini sold 322 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the transaction, the senior vice president directly owned 24,689 shares in the company, valued at $2,083,010.93. The trade was a 1.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $26,914.03. Following the completion of the transaction, the senior vice president directly owned 29,100 shares in the company, valued at $2,455,167. This trade represents a 1.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,946 shares of company stock valued at $324,420 over the last 90 days. Corporate insiders own 1.77% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Norges Bank purchased a new position in Itron in the 4th quarter worth about $63,990,000. Soros Fund Management LLC purchased a new stake in shares of Itron during the 4th quarter valued at about $34,843,000. Millennium Management LLC grew its stake in shares of Itron by 269.3% in the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock worth $47,068,000 after acquiring an additional 369,617 shares during the period. Merewether Investment Management LP grew its stake in shares of Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after acquiring an additional 282,587 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Itron by 20.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock valued at $137,659,000 after purchasing an additional 265,039 shares during the last quarter. 96.19% of the stock is owned by institutional investors.
Itron Company Profile
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Articles
- Five stocks we like better than Itron
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
